Click to Share
 
 
  1. Latest News
  2. Submit Press Release
  1. PR Home
  2. Latest News
  3. Feeds
  4. Alerts
  5. Submit Free Press Release
  6. Journalist Account
  7. PRNewswire Distribution
Filter News
Show All Results
News By Country
News By Tag
Tebu-bio Remove


August 2014
Sa Fr Th We Tu Mo Su
30 29 28 27 26 25 24

tebu-bio Press Releases

  + XML/RSS  



By tebu-bio
Researchers across Europe are now able to access StemCultures' FGF2 through tebu-bio’s pan-European network of offices.

By tebu-bio
tebu-bio announces today a distributor agreement with research antibody maker Biosensis bringing innovative tools for Life Sciences to European researchers

By tebu-bio
tebu-bio is proud to announce that they have been awarded the designation of Certified Service Provider (CSP) of RayBiotech’s antibody array testing services.

By tebu-bio
tebu-bio is pleased to announce their recent partnership with Smartox Biotechnology

By Sara Pierre - Communication Manager
tebu-bio is pleased to announce their agreement with CH3 BioSystems to distribute their product range to the European market.

By Sara Pierre - Communication Manager
Bromodomains are a new emerging class of pharmaceutical targets in the field of Epigenetics. Bromodomains (BRDs) are protein domains involved in Epigenetics that recognize acetylated lysines.

By Sara Pierre - Communication Manager
Stimulated Emission Depletion Microscopy (or STED nanoscopy) offers a technological breakthrough in the environment of cell imaging by drastically increasing the resolution over traditional confocal microscopy.

By Sara Pierre
tebu-bio is pleased to announce their recent distribution agreement with Sanguine BioSciences, Inc.

All Press Releases

By tebu-bio, Stemgent-Asterand
Stemgent-Asterand (http://www.stemgent.com), an innovative provider of  cellular reprogramming reagents and iPS cell reprogramming services, and tebu-bio (http://www.tebu-bio.com) are pleased to announce their new sales and marketing agreement...

By tebu-bio
Researchers across Europe are now able to access StemCultures' FGF2 through tebu-bio’s pan-European network of offices.

By tebu-bio
tebu-bio announces today a distributor agreement with research antibody maker Biosensis bringing innovative tools for Life Sciences to European researchers

By tebu-bio
tebu-bio is pleased to announce their recent distribution agreement with CellResearch Corporation Pte Ltd.

By tebu-bio
tebu-bio is proud to announce that they have been awarded the designation of Certified Service Provider (CSP) of RayBiotech’s antibody array testing services.

By tebu-bio
tebu-bio is pleased to announce their recent partnership with Smartox Biotechnology

By Sara Pierre - Communication Manager
tebu-bio is pleased to announce their agreement with CH3 BioSystems to distribute their product range to the European market.

By Sara Pierre - Communication Manager
Bromodomains are a new emerging class of pharmaceutical targets in the field of Epigenetics. Bromodomains (BRDs) are protein domains involved in Epigenetics that recognize acetylated lysines.

By Sara Pierre - Communication Manager
Stimulated Emission Depletion Microscopy (or STED nanoscopy) offers a technological breakthrough in the environment of cell imaging by drastically increasing the resolution over traditional confocal microscopy.

By Sara Pierre - Communication Manager
HypoThermosol® and CryoStor® Will Be Locally Available to the Broader European Research and Clinical Markets

By Sara Pierre
tebu-bio and XenoTech LLC co-organize a series of webinars focused on attaching human hepatocytes in ADME-TOX studies.

By Sara Pierre
tebu-bio is pleased to announce their recent distribution agreement with Sanguine BioSciences, Inc.

By Sara Pierre
tebu-bio is pleased to be participating at the ELA Screening Europe conference which will take place in Hamburg from June 30th to July 1st, 2011

By Sara Pierre
tebu-bio is pleased to announce the renewal for another three years, of their official recognition by the French Ministry of Higher Education & Research as an approved CRO (contract research organisation) within the French Research Tax Credit scheme.

By Sara Pierre
tebu-bio is pleased to announce their recent distribution agreement with Cellix Ltd.

By Sara Pierre
tebu-bio is pleased to announce the renewal of their agreement with Advanced Biotechnologies for the distribution of their products throughout Europe.

By Sara Pierre
Since the launch of their first mini-website dedicated to SilenciX, tebu-bio has subsequently released sites focussed on Preadipocytes and Antibody Arrays, with the most recent addition now centered around CryostaX™.

By Sara Pierre
tebu-bio will be attending the forthcoming ISNN congress "From reference intakes to personalized nutrition", which will take place in Pamplona, Spain, from November 18th to 20th, 2010.

By Sara Pierre
tebu-bio (Le Perray en Yvelines, France) is pleased to enter an agreement with Arbor Assays LLC, (Ann Arbor, USA) for the distribution of their products to a large number of European countries.

By Sara Pierre
tebu-bio is pleased to be attending the Hepatocyte User Group & Medicon Valley Hepatocytes User Forum which will take place in Montpellier, France, on October 22nd and 23rd 2010.

By Sara Pierre
Constantly seeking to enrich their range of laboratory services, tebu-bio is now offering Life Sciences researchers a standardized protein expression optimisation service in E. coli.

By TriLink BioTechnologies, Inc.
TriLink BioTechnologies, Inc. (TriLink), a leading provider of custom nucleic acid-based compounds, announced it has signed a distribution agreement permitting tebu-bio SA (tebu) to sell its CleanAmp™ products.

By Sara Pierre
tebu-bio announces the launch of their new website, providing European Life Sciences Researchers with a powerful tool to help them in their research

By Sara Pierre, tebu-bio
tebu-bio (Le Perray en Yvelines, France) and Platypus Technologies (Madison, USA) are pleased to announce their agreement to have tebu-bio distribute the Platypus Oris™ kits throughout Europe.

By Sara Pierre, tebu-bio
tebu-bio, in partnership with SABiosciences (Frederick, MD), is pleased to announce the launch of SilenciX cell lines in the USA

By Sara Pierre, tebu-bio
tebu-bio is pleased to announce their laboratories have recently received official recognition from the French Ministry of Higher Education and Research as an approved CRO (contract research organisation) within the French Research Tax Credit scheme.

By Sara Pierre, tebu-bio
Nadia Normand (BioAssay Manager - tebu-bio Laboratories) will be presenting the SilenciX cell lines at the upcoming 5th annual RNAi Europe conference, which will be held from September 16th to 18th in Stockholm and is dedicated to RNA interference.



Page:
  • 1

Page updated every 10 minutes


  1. SiteMap
  2. Contact PRLog
  3. Privacy Policy
  4. Terms of Service
  5. Copyright Notice
  6. About
  7. Advertise
Like PRLog?
9K2K1K
Click to Share